Literature DB >> 10759779

Complex pattern of Th1 and Th2 activation with a preferential increase of autoreactive Th1 cells in BALB/c mice with proteoglycan (aggrecan)-induced arthritis.

K Holló1, T T Glant, M Garzó, A Finnegan, K Mikecz, E Buzás.   

Abstract

The central role of CD4+ T cells and the balance between T helper (Th) subpopulations in the pathogenesis of autoimmune diseases have been extensively studied. Proteoglycan (aggrecan)-induced arthritis (PGIA) is a murine model for rheumatoid arthritis (RA), which is characterized by a Th1 dominance at the onset of the disease. In addition to CD4+ T cells, antigen-presenting B cells and autoantibodies seem to play an important role in the development and regulation of PGIA. To identify proteoglycan-specific CD4+ T cell subsets and Th1- and Th2-supported antibody isotypes during the progression of PGIA, spleen cells of proteoglycan-immunized BALB/c mice were harvested at different times of immunization, and at different stages of the disease, and their cytokine production and antigen-specific antibody isotype profiles were determined by enzyme-linked immunospot (ELISPOT) assays. Both Th1 and Th2 cytokine-producing cells, with the predominance of IL-4/IL-5-secreting cells, were detected during the prearthritic stage, and a shift toward a Th1 dominance was observed at the time of onset of arthritis. Tissue homogenates of acutely inflamed joints contained significantly higher levels of interferon-gamma than IL-4. The prearthritic period and both the acute and chronic phases of joint inflammation were characterized by IgG1 dominance in the sera and this correlated with the number of IgG1-secreting B cells in the spleen. However, the ratio of autoreactive IgG1/IgG2a-secreting cells decreased in arthritic animals. These results indicate the activation and possible regulatory roles of both Th1 and Th2 subsets in the autoimmune process, with the necessity of a relative increase of autoreactive Th1 cells for the induction of joint inflammation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10759779      PMCID: PMC1905608          DOI: 10.1046/j.1365-2249.2000.01174.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  36 in total

1.  Changes in cytokine secretion induced by altered peptide ligands of myelin basic protein peptide 85-99.

Authors:  L J Ausubel; J I Krieger; D A Hafler
Journal:  J Immunol       Date:  1997-09-01       Impact factor: 5.422

2.  The Th1-Th2 model--what relevance to inflammatory arthritis?

Authors:  P D Kiely
Journal:  Ann Rheum Dis       Date:  1998-06       Impact factor: 19.103

3.  Prognostic value of Th1/Th2 ratio in rheumatoid arthritis.

Authors:  W L van der Graaff; A P Prins; B A Dijkmans; R A van Lier
Journal:  Lancet       Date:  1998-06-27       Impact factor: 79.321

4.  Critical roles of glycosaminoglycan side chains of cartilage proteoglycan (aggrecan) in antigen recognition and presentation.

Authors:  T T Glant; E I Buzás; A Finnegan; G Negroiu; G Cs-Szabó; K Mikecz
Journal:  J Immunol       Date:  1998-04-15       Impact factor: 5.422

5.  CD4+ Th2 cells specific for mycobacterial 65-kilodalton heat shock protein protect against pristane-induced arthritis.

Authors:  J T Beech; L K Siew; M Ghoraishian; L M Stasiuk; C J Elson; S J Thompson
Journal:  J Immunol       Date:  1997-10-15       Impact factor: 5.422

6.  Conversion in vivo from an early dominant Th0/Th1 response to a Th2 phenotype during the development of collagen-induced arthritis.

Authors:  A Doncarli; L M Stasiuk; C Fournier; O Abehsira-Amar
Journal:  Eur J Immunol       Date:  1997-06       Impact factor: 5.532

7.  Cytokine production in synovial tissue of mice with collagen-induced arthritis (CIA).

Authors:  A Müssener; M J Litton; E Lindroos; L Klareskog
Journal:  Clin Exp Immunol       Date:  1997-03       Impact factor: 4.330

8.  Analysis of type 1 and type 2 T cells in synovial fluid and peripheral blood of patients with rheumatoid arthritis.

Authors:  M Kusaba; J Honda; T Fukuda; K Oizumi
Journal:  J Rheumatol       Date:  1998-08       Impact factor: 4.666

9.  Progressive polyarthritis induced in BALB/c mice by aggrecan from normal and osteoarthritic human cartilage.

Authors:  T T Glant; G Cs-Szabó; H Nagase; J J Jacobs; K Mikecz
Journal:  Arthritis Rheum       Date:  1998-06

10.  Reduced susceptibility to collagen-induced arthritis in mice deficient in IFN-gamma receptor.

Authors:  Y Kageyama; Y Koide; A Yoshida; M Uchijima; T Arai; S Miyamoto; T Ozeki; M Hiyoshi; K Kushida; T Inoue
Journal:  J Immunol       Date:  1998-08-01       Impact factor: 5.422

View more
  17 in total

1.  Presentation of the candidate rheumatoid arthritis autoantigen aggrecan by antigen-specific B cells induces enhanced CD4(+) T helper type 1 subset differentiation.

Authors:  Caroline L Wilson; Dominic W Hine; Ariel Pradipta; Jeffrey P Pearson; Willem van Eden; John H Robinson; Andrew M Knight
Journal:  Immunology       Date:  2012-04       Impact factor: 7.397

2.  Differential regulation of osteoblast activity by Th cell subsets mediated by parathyroid hormone and IFN-gamma.

Authors:  Nathan Young; Natallia Mikhalkevich; Ying Yan; Di Chen; Wei-ping Zheng
Journal:  J Immunol       Date:  2005-12-15       Impact factor: 5.422

3.  Intradermal active full-length DNA Aβ42 immunization via electroporation leads to high anti-Aβ antibody levels in wild-type mice.

Authors:  Roger N Rosenberg; Min Fu; Doris Lambracht-Washington
Journal:  J Neuroimmunol       Date:  2018-06-11       Impact factor: 3.478

4.  Immunogenicity of recombinant human bocavirus-1,2 VP2 gene virus-like particles in mice.

Authors:  Zhong-Hua Deng; Ye-Xia Hao; Li-Hong Yao; Zhi-Ping Xie; Han-Chun Gao; Le-Yun Xie; Li-li Zhong; Bing Zhang; You-De Cao; Zhao-Jun Duan
Journal:  Immunology       Date:  2014-05       Impact factor: 7.397

5.  Anti-inflammatory and chondroprotective effect of TSG-6 (tumor necrosis factor-alpha-stimulated gene-6) in murine models of experimental arthritis.

Authors:  T Bárdos; R V Kamath; K Mikecz; T T Glant
Journal:  Am J Pathol       Date:  2001-11       Impact factor: 4.307

6.  Proteoglycan-induced arthritis and recombinant human proteoglycan aggrecan G1 domain-induced arthritis in BALB/c mice resembling two subtypes of rheumatoid arthritis.

Authors:  Tibor T Glant; Marianna Radacs; Gyorgy Nagyeri; Katalin Olasz; Anna Laszlo; Ferenc Boldizsar; Akos Hegyi; Alison Finnegan; Katalin Mikecz
Journal:  Arthritis Rheum       Date:  2011-05

7.  Continuous nasal administration of antigen is critical to maintain tolerance in adoptively transferred autoimmune arthritis in SCID mice.

Authors:  T Bárdos; M Czipri; C Vermes; J Zhang; K Mikecz; T T Glant
Journal:  Clin Exp Immunol       Date:  2002-08       Impact factor: 4.330

8.  Development of proteoglycan-induced arthritis is independent of IL-17.

Authors:  Paul D Doodes; Yanxia Cao; Keith M Hamel; Yumei Wang; Balint Farkas; Yoichiro Iwakura; Alison Finnegan
Journal:  J Immunol       Date:  2008-07-01       Impact factor: 5.422

9.  Age-related changes in arthritis susceptibility and severity in a murine model of rheumatoid arthritis.

Authors:  Oktavia Tarjanyi; Ferenc Boldizsar; Peter Nemeth; Katalin Mikecz; Tibor T Glant
Journal:  Immun Ageing       Date:  2009-06-11       Impact factor: 6.400

10.  Antigen-specific B lymphocytes acquire proteoglycan aggrecan from cartilage extracellular matrix resulting in antigen presentation and CD4+ T-cell activation.

Authors:  Marzena Ciechomska; Caroline L Wilson; Achilleas Floudas; Wang Hui; Andrew D Rowan; Willem van Eden; John H Robinson; Andrew M Knight
Journal:  Immunology       Date:  2014-01       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.